Ning Li, Ph.D
Oriza Seed Ventures
Dr. Ning Li is Investment Director at Oriza Seed, a leading venture capital firm since 2015, where he is primarily focused on life science investments.
His portfolio includes EpimAb Biotherapeutics, CStone Pharmaceuticals, TenNor Therapeutics, Ark Biosciences, Gene Quantum, among others.
Prior to that, Dr. Li served at WuXi AppTec, a leading global contract research outsourcing provider, and led efforts in discovery and development of international and internal R&D projects in the fields of oncology, infectious, metabolic and inflammatory diseases. He received his PhD in Drug Design from the Chinese Academy of Sciences.